Abbott To Pay $52M To Norvir Direct Purchaser Class
Abbott Laboratories agreed in a California federal court on Friday to pay direct purchasers of its HIV drugs Norvir and Kaletra $52 million to resolve a consolidated antitrust class action....To view the full article, register now.
Already a subscriber? Click here to view full article